PACB on a long ramp up

Great company with a good competitive product revealed a breakthrough in genetic sequencing long awaited by the early investors who paid $16 for their positions as can be seen in this weekly chart (upper left). They believe it is worth that, risk adjusted, so, likely in the $25 range if successful. They were. Sustainable lead is a critical new study field, gene sequencing with an affordable fast long sequence machine.
Motley Fool recommended as a long term hold, at $14.
Buy signal from the CM_Ultimate_MA was at $4.50, entered at $4.76, then again at $7.00. Considering adding to the position as it breaks resistance then pulls back.